A company developing an incisionless, implantable antiobesity medical device has made an early close of $3.1 million on a series B round of investment that’s expected to reach $5 million. Columbus, Ohio-based EndoSphere will use the series B to commercially launch its Satisphere innovative medical device, which received the CE Mark recently. Additionally, EndoSphere plans […]
An incisionless, implantable antiobesity medical device from EndoSphere has received the CE Mark, which signifies European regulatory approval. EndoSphere’s device, called the Satisphere, works by slowing the passage of food through the duodenum, the upper part of the smaller intestine that breaks down food. Because food is in contact with the duodenum for a longer […]
Previously a virtual company in California, medical device maker Endosphere is heading to Ohio to become a reality. Endosphere, which is developing an implantable and incisionless weight-loss device, was lured to Ohio by the promise of investment dollars.
